- Stocks
- Pages
- Blogs
- Research Reports
India – US Trade Deal

View

share-market-today

View

stocks

View

blog author

View

Author

View

Research Baskets

View

high stocks test page

View

MF_API

View

Holiday

View

API_DATA

View

Portfolio Allocation Strategy During Interest Rate Cycles
30 June 2026
Read Blog

What happens after a company gets delisted?
19 June 2026
Read Blog

FII vs DII: Key Differences Explained
16 June 2026
Read Blog

What Is REIT?
15 June 2026
Read Blog

Difference Between Bull and Bear Market
12 June 2026
Read Blog

What is IOC in Share Market?
11 June 2026
Read Blog

What Is a Short Delivery in Share Market?
10 June 2026
Read Blog

How to Handle Stock-Specific Risk in Long-Term Portfolios
9 June 2026
Read Blog

When Should You Cut Losses in Stocks? A Smart Investor’s Guide
25 May 2026
Read Blog

Electronic Gold Receipts (EGR): Meaning, Features & How They Work in India
19 May 2026
Read Blog

View All Blogs

Conect – Apr-Jun’26 Results – Highest growth since 4Q24 as demand remains steady
31 August 2026
Read Report

Fractal Analytics (FRACTAL IN) – Annual Report Analysis – Assets reusability complements margins improvement – BUY
31 August 2026
Read Report

SIS (SECIS IN) – Management Meet Update – Prime beneficiary of new wage code norms – Not Rated
31 August 2026
Read Report

Chemicals – Manthan – The dragon’s hegemony | tough days ahead for battery value chain in India
31 August 2026
Read Report

The Beat – DCX Systems set for a booming upside!
02 January 2025
Read Report

HDFC Bank (HDFCB IN) – Event Update – MD & CEO, Mr. Jagdishan decides not to continue – BUY
31 August 2026
Read Report

JSW Steel (JSTL IN) – Q3FY25 Result Update – Better quarter, but HRC situation yet to improve – HOLD
27 January 2025
Read Report

Technical Newsletter: 28-Aug-2026
28 August 2026
Read Report

ICICI Bank (ICICIBC IN) – Q3FY25 Result Update – Asset quality remains best-in-class – BUY
27 January 2025
Read Report

Technical Newsletter: 27-Aug-2026
27 August 2026
Read Report

View All Reports
Login
Open Account

Coral Laboratories Ltd

Small Cap | Pharmaceuticals

₹ 622.15 -21(-3.27%)

Last updated: 31-Aug-2026 , 16:01:29

Performance

Low: ₹619 High: 643.15

Previous Close	₹ 643.15
High	₹ 643.15
Volume	1914
52W Range	₹ 360 - ₹ 679

Open	₹ 643.15
Low	₹ 619
Market Cap	₹ 207.76 Cr

Coral Laboratories Ltd Technicals

Current Price

₹ 622.15 -21 (-3.27%)

EMASMA

20 Day	₹ 618.279
50 Day	₹ 587.830
100 Day	₹ 550.356
200 Day	₹ 533.716

20 Day	₹ 608.600
50 Day	₹ 601.339
100 Day	₹ 527.959
200 Day	₹ 489.169

Coral Laboratories Ltd Fundamentals

ROCE	10.893
P/E Ratio	11.560
P/B Ratio	1.060
Industry P/E	1.060
Debt to Equity	51.431

ROE	7.834
EPS	53.800
Dividend Yield	0.320
Book Value	585.742
Face Value	10.000

Coral Laboratories Ltd Financials

Particulars	Y202503	Y202403	Y202303	Y202203	Y202103
Total Revenue	124.1139	90.2928	85.0135	80.4245	100.3373
Total Expenses	90.8741	69.3973	76.8255	69.5282	82.7435
Profit After Tax	24.1556	15.789	6.4454	9.0457	13.5546

Coral Laboratories Ltd Shareholding Pattern

Promoter Holdings	71.511 %
FIIs	0.000 %
DIIs	0.000 %
MutualFund	0.000 %
Retail	19.928 %
Others -	8.561 %

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February, 1997. It was promoted by Navin B Doshi of the DWD Group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial production at Dehradun Plant in September, 2006. Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. It produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals	₹ 44.71 +1.54 (+3.57%)
Amrutanjan Health Care Ltd Pharmaceuticals	₹ 510.00 -5.35 (-1.04%)
Astrazeneca Pharma India Ltd Pharmaceuticals	₹ 7,100.00 -6.25 (-0.09%)
Bliss GVS Pharma Ltd Pharmaceuticals	₹ 616.40 +29.35 (+5%)
Abbott India Ltd Pharmaceuticals	₹ 25,900.00 -395.7 (-1.5%)
Cipla Ltd Pharmaceuticals	₹ 1,416.00 -2 (-0.14%)

FAQs on Coral Laboratories Ltd

1. Can I buy Coral Laboratories Ltd from PL Capital? ›

Yes, you can invest in Coral Laboratories Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Coral Laboratories Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Coral Laboratories Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Coral Laboratories Ltd pay dividends? ›

Yes, Coral Laboratories Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Coral Laboratories Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Coral Laboratories Ltd ? ›

As of 31-Aug-2026 , 16:01:29 the share price for Coral Laboratories Ltd. is ₹ 622.15 on the NSE (Note: Prices are dynamic and update frequently during market hours).